Amgen licenses cancer drug to NatPharma
Amgen has licensed an experimental cancer drug to a Chicago biotech company founded and controlled by billionaire Patrick Soon-Shiong. NatPharma LLC is licensing the rights to AMG 337 from Thousand Oaks-based Amgen to develop and sell AMG 337. The drug is an experimental, phase-two cancer treatment. The licensing agreement is the second between Amgen and Read More →
Goleta-based Deckers hits 52-week low for stock price
Goleta-based Deckers Brands hit a 52-week low on Sept. 11 when it briefly fell to $59.62 per share. It closed Sept. 14 at $61.10. Shares of Deckers dropped about 33 percent so far this year from $89.74 on Jan. 2 before it closed at $60.65 on Sept. 11. Investment research firm Zacks said weak earnings Read More →
Dubroff: Investors should be skeptical about exchange-traded funds
Exchange-traded funds are the newest, latest, greatest Wall Street creation. In the past decade and a half, they’ve grown from a niche product with just $72 billion in assets invested to a behemoth totaling $2.7 trillion. Thanks to real-time daily pricing and low fees, ETFs are rapidly supplanting mutual funds in retail accounts. But the Read More →
Oil company wants to expand Orcutt drilling despite pipe closures
Since Plains All American Pipeline shut down Lines 901 and 903 in May after the Refugio oil spill, Pacific Coast Energy is one of only a few oil producers in the county able to get its product to market. The Orcutt-based business, which operates under its Los Angeles-based parent company Breitburn Energy, is trying to Read More →
Citizens Business Bank targets Tri-Counties for growth
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
